Clicking the 'Yes' link below will take you out of the Abbott Laboratories family of websites. Links which take you out of Abbott Laboratories worldwide web sites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the contents of any such site or any further links from such site. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott Laboratories.

Do you wish to continue?


Print Print | Text Size Decrease font size Increase font size

Welcome

Relief, confidence, freedom from stress. We understand that prenatal testing can play an important role in a woman's pregnancy. This website strives to promote awareness of prenatal testing by providing information about AneuVysion and prenatal testing resources.

Thanks for visiting and please explore the links on the left to get started.

 

Intended Use

The AneuVysion (Vysis CEP 18, X, Y-alpha satellite, LSI 13 and 21) Multicolor Probe Panel is  intended to use CEP 18/X/Y probe to detect alpha satellite sequences in the centromere regions  of chromosomes 18, X, and Y, and LSI 13/21 probe to detect the 13q14 region and the 21q22.13  to 21q22.2 region. The AneuVysion kit is indicated for identifying and enumerating chromosomes  13, 18, 21, X, and Y via fluorescence in situ hybridization (FISH) in metaphase cells and  interphase nuclei obtained from amniotic fluid in subjects with presumed high risk pregnancies.  It is not intended to be used as a stand alone assay for making clinical decisions. FISH results  are intended to be used as an aid in the diagnosis of numerical abnormalities of chromosomes  13, 18, 21, X and/or Y in conjunction with other information currently used in prenatal diagnosis,  consistent with professional standards of practice.1 This device is intended for use only with  amniocyte cells; it is not intended for and has not been validated for use with other test matrices.  This FISH assay will not detect the presence of structural chromosome abnormalities that can  also result in birth defects. This FISH assay will be performed in cytogenetics laboratories.

Reference

1. American College of Medical Genetics. Technical and clinical assessment of fluorescence in situ hybridization: an ACMG/ASHG position statement. I. Technical considerations. Genetics in Medicine 2000;2(6):356-361.

Print Print

 

Privacy Policy | Terms and Conditions
Copyright © Abbott Laboratories. Abbott Park, Illinois, U.S.A.

This website and the information contained herein are intended for use by US residents only, are provided for informational purposes only and are not intended to replace a discussion with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider and consider the unique characteristics of each patient.